Peripersonal Space Representation in Upper Limb Segmental Exclusion
Study of the Representation of Action Peripersonal Space in Participants With Unilateral Segmental Exclusion of the Upper Limb Compared to Asymptomatic Subjects
2 other identifiers
observational
60
1 country
1
Brief Summary
This study aims to evaluate the representation of action peripersonal space (PPS) in subjects suffering from unilateral segmental exclusion syndrome of the upper limb compared to healthy control subjects. Segmental exclusion is defined by non-use or under-use of a limb segment without central nervous system damage. The study hypothesizes that this syndrome leads to a modification (shrinkage) of the PPS representation. Participants will perform reachability judgments in a Virtual Reality (VR) environment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 4, 2025
CompletedFirst Submitted
Initial submission to the registry
January 8, 2026
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
March 16, 2026
March 1, 2026
1.6 years
January 8, 2026
March 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Judgment Error of Reachability
The Judgment Error of Reachability is a single composite metric calculated as: ((DMA-p - DMA-r) / DMA-r) × 100, expressed as a percentage (%). Both DMA-p (Perceived Maximum Reachable Distance) and DMA-r (Real Maximum Reachable Distance) are measured in centimeters, and their ratio yields a single dimensionless percentage score.
Day 1 (During the 40-minute VR assessment)
Secondary Outcomes (5)
Body Perception Disturbance Score
Day 1 (Before VR task)
Functional Impairment Score (400-Point Hand Assessment)
Day 1
Anxiety and Depression Score (HAD)
Day 1
Kinesiophobia Score (Tampa Scale)
Day 1
Pain Catastrophizing Score (PCS)
Day 1
Study Arms (2)
Patients with Exclusion
Patients presenting with unilateral segmental exclusion of the upper limb or part of the hand evolving for more than 3 months.
Healthy Controls
symptomatic volunteers with no history of upper limb impairment with sequelae.
Interventions
Participants wear an Oculus Quest 2 VR headset. They first perform a motor task to measure Real Reachable Distance (DMA-r). Then, they perform a perceptual task where they must judge, without moving, if a virtual object is reachable (DMA-p). The test evaluates different spatial planes (front, 45° right, 45° left) and heights (shoulder, navel).
Eligibility Criteria
he study population consists of two groups recruited at the Institut Régional de Réadaptation (Centre Louis Pierquin, UGECAM Nord-Est) in Nancy, France. Patients with Exclusion: Participants are selected from patients receiving routine care (full hospitalization or day hospital) at the center. They are identified based on a functional assessment ("Bilan 400 points") showing specific impairments related to unilateral upper limb exclusion evolving for more than 3 months. Healthy Controls: Asymptomatic volunteers are recruited through the social or family network of the investigators and current participants, as well as via posters displayed in the UGECAM centers.
You may qualify if:
- Age ≥ 18 years.
- No contraindication to force work in daily activities.
You may not qualify if:
- Affiliated to a social security scheme.
- Able to understand simple orders.
- Age ≥ 18 years.
- No history of upper limb impairment with sequelae.
- Visual impairments.
- Central neurological pathology.
- Unstabilized psychiatric pathology.
- Communication or comprehension difficulties.
- Under legal protection or unable to consent.
- Pregnant or breastfeeding women.
- Cervical pathology contraindicating VR headset use.
- Epilepsy.
- Inability to stand for 40 minutes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut Régional de Médecine Physique et de Réadaptation (IRR), Centre Louis Pierquin.
Nancy, 54000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2026
First Posted
January 16, 2026
Study Start
December 4, 2025
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
March 16, 2026
Record last verified: 2026-03